Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8220948 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 7 Pages |
Abstract
Although HNC patients receiving IMRT will likely experience reduced xerostomia and dysphagia symptoms, the small quality-of-life benefit associated with IMRT is not cost-effective in the short term but may be cost-effective over a patient's lifetime, assuming benefits persist over time and patients are healthy and likely to live for a sustained period. Additional data quantifying the long-term benefits of IMRT, however, are needed.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Racquel E. MSPH, Nathan C. MD, Stephanie B. PhD, MPH, Chris FRCP, FRCR, MD, PhD, Emma PhD, Bhishamjit S. MD,